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Abstract
AIM
To summarize the reported Middle East respiratory 
syndrome-coronavirus (MERS-CoV) cases, the asso-
ciated clinical presentations and the outcomes. 
METHODS
We searched the Saudi Ministry of Health website, the 
World Health Organization website, and the Flutracker 
website. We also searched MEDLINE and PubMed 
for the keywords: Middle East respiratory syndrome-
coronavirus, MERS-CoV in combination with pediatric, 
children, childhood, infancy and pregnancy from the initial 
discovery of the virus in 2012 to 2016. The retrieved 
articles were also read to further find other articles. Rele-
vant data were placed into an excel sheet and analyzed 
accordingly. Descriptive analytic statistics were used in 
the final analysis as deemed necessary.
RESULTS
From June 2012 to April 19, 2016, there were a total 
of 31 pediatric MERS-CoV cases. Of these cases 13 
(42%) were asymptomatic and the male to female ratio 
was 1.7:1. The mean age of patients was 9.8 ± 5.4 
years. Twenty-five (80.6%) of the cases were reported 
from the Kingdom of Saudi Arabia. The most common 
source of infection was household contact (10 of 15 
with reported source) and 5 patients acquired infection 
within a health care facility. Using real time reverse 
transcriptase polymerase chain reaction of pediatric 
patients revealed that 9 out of 552 (1.6%) was positive 
in the Kingdom of Saudi Arabia. 
CONCLUSION
Utilizing serology for MERS-CoV infection in Jordan and 
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Saudi Arabia did not reveal any positive patients. Thus, 
the number of the pediatric MERS-CoV is low; the exact 
reason for the low prevalence of the disease in children 
is not known. 
Key words: Pediatric; Middle East respiratory syndrome-
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Core tip: The number of the pediatric Middle East 
respiratory syndrome-coronavirus (MERS-CoV) is low 
and the exact reason for the low prevalence is not 
known. A total of 31 pediatric MERS-CoV cases were 
reported since June 2012. Of all the cases 13 (42%) 
were asymptomatic and the male to female ratio was 
1.7:1. The mean age of patients was 9.8 ± 5.4 years.
The most common source of infection was household 
contact followed by infection within a health care facility. 
Using real time reverse transcriptase polymerase chain 
reaction of pediatric patients revealed that 9 out of 552 
(1.6%) was positive in the Kingdom of Saudi Arabia. 
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INTRODUCTION
Middle East respiratory syndrome-coronavirus (MERS-
CoV) was first isolated in 2012 from a patient in the 
Kingdom of Saudi Arabia (KSA)[1]. As more cases were 
reported, the case fatality rate changed to 40% from 
60%[2-5]. In addition, initially there was a predominance 
of males; later this ratio decreased[2,6]. MERS-CoV is 
characterized by three different patterns of disease: 
Sporadic cases, intra-familial transmission[7-9] and health 
care associated infection[2,3,10-16]. Despite the increased 
number overtime and the multiple health care associated 
outbreaks[17], the number of pediatric cases remained 
low during the study period[18]. The initial description of 
47 cases included only a 14-year-old child[4]. The first 
pediatric case was a 2-year-old child reported from 
Jeddah, KSA on June 28, 2013[19]. Later an additional 
three asymptomatic children were reported[4]. The 
largest report of childhood MERS-CoV cases included 
eleven, of which two patients were symptomatic and 
nine were asymptomatic[18]. The exact reason for this low 
prevalence of the disease in children is not known. In this 
study, we summarize the reported MERS-CoV cases and 
the associated clinical presentation and the outcome.
MATERIALS AND METHODS
We searched the Saudi Ministry of Health website[20], 
the World Health Organization website[21], the Flutracker 
website[22], the medical literature and the retrieved 
published studies for any childhood MERS-CoV infections. 
We searched MEDLINE and PubMed for the keywords 
Middle East respiratory syndrome-coronavirus, MERS-
CoV, in combination with pediatric, children, childhood, 
infancy and pregnancy from the initial discovery of the 
virus in June 2012 until April 19, 2016. The retrieved 
articles were also read to find other relevant articles. 
Statistical analysis
Relevant data were placed into an excel sheet and analyzed 
accordingly. Descriptive analytic statistics were used in 
the final analysis as deemed necessary, including mean 
and standard deviation when applicable and frequency. 
The statistical review of the study was performed by a 
biomedical statistician. Statistical review is performed 
before the submission of the manuscript.
RESULTS
Summary of pediatric cases
From June 2012, to April 19, 2016, there were a total of 
31 pediatric MERS-CoV cases as shown in Table 1. Of all 
the cases, thirteen (13) or 42% were asymptomatic, and 
there were 17 males, 10 females and 4 unreported (a 
male to female ratio of 1.7:1). The mean age of patients 
was 9.8 + 5.4 (0.75-17) years. Twenty-five cases 
(80.6%) were reported from KSA; the other patients 
were in Jordan, United Arab Emirates and the Republic 
of Korea (Table 1). The most common source of the 
infection was household contact (10 of 15 with reported 
source), and 5 patients acquired the infection within 
a health care facility. About one half of the cases were 
reported in 2014, and 29% were reported in 2013 and 
22.6% in 2015 (Table 2).
Screening of pediatric patients for MERS-CoV
Screening of pediatric patients for MERS-CoV infection 
using real time reverse transcriptase polymerase chain 
reaction showed that only 9 out of 552 (1.6%) were 
positive in KSA[23]. However, serologic testing of pe-
diatric patients admitted with lower respiratory tract 
infection in Jordan and Saudi Arabia revealed no positive 
tests[24,25] (Table 3).
Pregnancy associated MERS-COV
The effect of MERS-CoV infection on the fetus was 
described in eight cases[26-29] as summarized in Table 4. 
The mean age of the mothers was 32.25 + 3.4 years, 
and the mean gestational age was 28.4 + 6.3 wk. 
Death of the fetus was observed in 3 (37.5%) of the 8 
fetuses.
DISCUSSION
Despite the total number of MERS cases increasing, 
especially in KSA, the number of pediatric cases 
remained low during the study period. Initially, the 
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The pattern of MERS-CoV pediatric cases was similar 
to the 2003 SARS outbreak. Children were less affected 
than adults and children less than 2 years of age had 
milder disease[31]. In the largest screening of contacts, 
the rate of MERS-CoV positive children (1.6%, 9/616) 
compared to 2.2% (99/4440) in adults (P = 0.23)[23]. 
Thus, in this study utilizing MERS-CoV PCR the positivity 
rate did not differ in children and adults. 
In adults with MERS-CoV infections, three patterns 
of transmissions were observed: Sporadic (primary) 
cases presumed to be due to animal exposure (mainly 
camels), household contacts or health care associated 
infections[32]. In KSA, the majority (45%) of cases were 
health care-associated infections, 38% were primary 
cases, and 13% were household contacts[32]. In contrast, 
in the majority of pediatric cases that reported source of 
acquisition (66.7% of the 15 with reported source), the 
disease was acquired through household contact. This 
pattern indicates a low exposure of children to animals 
and a higher rate of health care associated infections in 
adult wards. The male to female ratio (2.8:1 and 3.3:1) 
was initially high[3,4]. This apparent male predominance 
could be explained by the nature of hospital outbreaks[2]. 
Eventually the male to female ratio was reduced to 1.3:1 
to 1.8:1[5,6]. Consistent with these studies, the male to 
female ratio in children with MERS-CoV was 1.7:1 and 
may indicate similar exposure of children to index cases 
in the household settings and differential host factors.
Possible explanations for the lower number of pe-
diatric cases compared to adults include differential 
testing of adult patients and milder diseases in children; 
although, serologic testing of pediatric patients in KSA 
and Jordan did not reveal any positive cases[24,25]. In the 
largest sero-epidemiologic survey in KSA, the study did 
not include children and thus it is difficult to establish 
the rate of sero-positivity in children[31].
The MERS-CoV infection rate in children remains low 
and possible explanations include: A milder disease in 
children, asymptomatic infection, or the presence of yet to 
be identified factors. The development of a shorter duration 
of MERS in children is another possible explanation. If this 
is the case, it may limit the development of a positive 
serology. In one study, delayed antibody responses as 
measured with the neutralization test was associated 
with severe diseases[33]. The longevity of antibodies in 
MERS-CoV cases might be limited as was the case with 
SARS[33,34]. The only study of serology among children was 
done among hospitalized pediatric cases who presented 
with lower respiratory tract infections[25]. There is no 
systematic screening of exposed children using serologic 
testing; this limited the interpretation of available ser-
ologic studies.
Little data also exist regarding the effect and the 
likelihood of MERS-CoV in pregnancy. Eight cases were 
reported[26,27,29]. The outcome was favorable in the 
majority of cases. The exact prevalence of MERS-CoV 
antibodies and exposure of pregnant women to MERS-
CoV is not known.
In conclusion, the number of MERS-CoV infections 
in pediatric patients remains low. Possible explanations 
include low exposure, presence of asymptomatic, mildly 
symptomatic patients or the presence of yet to be 
identified factors. The immune system predisposing to 
severe disease and to fatal outcome remains unknown. 
An exploration of the virus-host interaction may add 
No. %
Male:female 17:10 (1.7:1) 63 vs 37
Saudi 20    83.3
City
   Jeddah   7    29.2
   Riyadh   7    29.2
   Hafr al-Batin   3    12.5
   Symptomatic 12    50.0
   Death   8    33.3
Year of report
   2013   9 29
   2014 15    48.4
   2015   7    22.6
Table 2  Summary of the demographic characteristics of 
pediatric Middle East respiratory syndrome-coronavirus
Age of the 
patient (yr)
Gestational 
age
Fetal 
outcome
Diagnostic 
test
Country Ref.
39 5 mo Still birth Antibody by 
EIA
Jordan [26]
33 32 wk Healthy 
infant
PCR Saudi Arabia [27]
32 32 wk Healthy PCR United Arab 
Emirates
[28]
34 34 wk Died PCR Saudi Arabia [29]
32 38 wk Survived PCR Saudi Arabia [29]
31 24 wk Died PCR Saudi Arabia [29]
27 22 wk Survived PCR Saudi Arabia [29]
30 23 wk Survived PCR Saudi Arabia [29]
PCR: Polymerase chain reaction; EIA: Enzyme immunoassay.
Table 4  Summary of pregnancy associated Middle East 
respiratory syndrome-coronavirus infection
Country Testing 
method
Population Positive n  (%) Yr Ref.
KSA rRT-PCR Screening of 
children
     9/552 (1.6) [23]
KSA Neutralizing 
antibodies 
testing
Serum samples 
from children 
hospitalized 
for lower 
respiratory tract 
infections
  0/158 (0) May 
2010-May 
2011
[25]
Jordan rRT-PCR Hospitalized 
children < 2 yr 
of age
0/2427 (0) [24]
rRT-PCR: Real time reverse transcriptase polymerase chain reaction; KSA: 
Kingdom of Saudi Arabia.
Table 3  Summary of different studies examining Middle East 
respiratory syndrome-coronavirus infection in children
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to the understanding of the low prevalence in this age 
group.
COMMENTS
Background
Middle East respiratory syndrome-coronavirus (MERS-CoV) was first isolated in 
2012 from a patient in the Kingdom of Saudi Arabia (KSA). Despite the increased 
number of MERS-CoV cases overtime, the number of pediatric cases remained 
low. The exact reason for this low prevalence of the disease in children is not 
known. The aim of this study is to summarize the reported MERS-CoV cases and 
the associated clinical presentation and the outcome.
Research frontiers
The first pediatric case was a two-year-old child reported from Jeddah, KSA on 
June 28, 2013. Later an additional three asymptomatic children were reported. 
The largest report of childhood MERS-CoV cases included eleven, including 
nine asymptomatic cases. 
Innovations and breakthroughs
The number of MERS-CoV infections in pediatric patients remains low. Possi-
ble explanations include low exposure, presence of asymptomatic, mildly 
symptomatic patients or the presence of yet to be identified factors. The immune 
system predisposing to severe disease and to fatal outcome remains unknown. 
An exploration of the virus-host interaction may add to the understanding of the 
low prevalence in this age group.
Applications
Despite the low number of pediatric MERS-CoV cases, it is important to continue 
to monitor the development of this disease in this age group and to understand 
the risk factors.
Terminology
MERS-CoV is a new emerging virus that was first isolated in 2012.
Peer-review
This complication of all known pediatric cases is a useful contribution to the 
medical literature, and knowing it is possible but rare is important.
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